Alessio Gabellini

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Drug Administration

Induced Pluripotent Stem Cells

Cross Sectional

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Dina Manetti, Silvia Dei, Hugo R Arias, Laura Braconi, Alessio Gabellini, Elisabetta Teodori, Maria Novella Romanelli
Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators. Molecules (Basel, Switzerland) 28 (3) (2023)
Dina Manetti, Silvia Dei, Hugo R Arias, Laura Braconi, Alessio Gabellini, Elisabetta Teodori, Maria Novella Romanelli
Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators. Molecules (Basel, Switzerland) 28 (3) (2023)
Dina Manetti, Silvia Dei, Hugo R Arias, Laura Braconi, Alessio Gabellini, Elisabetta Teodori, Maria Novella Romanelli
Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators. Molecules (Basel, Switzerland) 28 (3) (2023)
Maria Novella Romanelli, Laura Braconi, Alessio Gabellini, Dina Manetti, Giambattista Marotta, Elisabetta Teodori
Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023. Molecules (Basel, Switzerland) 29 (1) (2023)
Maria Novella Romanelli, Laura Braconi, Alessio Gabellini, Dina Manetti, Giambattista Marotta, Elisabetta Teodori
Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023. Molecules (Basel, Switzerland) 29 (1) (2023)
Niccolò Chiaramonte, Alessio Gabellini, Andrea Ageli, Gianluca Bartolucci, Laura Braconi, Silvia Dei, Elisabetta Teodori, Claudiu T Supuran, Maria Novella Romanelli
New Histamine-Related Five-Membered N-Heterocycle Derivatives as Carbonic Anhydrase I Activators. Molecules (Basel, Switzerland) 27 (2) (2022)